2001
DOI: 10.1016/s0196-9781(01)00409-0
|View full text |Cite
|
Sign up to set email alerts
|

Retro-inverso peptide analogues of Trypanosoma cruzi B13 protein epitopes fail to be recognized by human sera and peripheral blood mononuclear cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0

Year Published

2003
2003
2012
2012

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(8 citation statements)
references
References 42 publications
0
8
0
Order By: Relevance
“…(3) Y171(4) E63 (5) E63(3) Y159 (4) Y159 (3) K66 (2) T163 (2) Ile2P Y159 (2) Y159 (5) E63 (1) E63 (5) K66 (6) K66(3) E24 (5) E24 (4) Y45 (1) N70 (4) K66 (2) Ile3P Y159 (11) Y159 (17) R155 (2) S99 (2) L156 (1) Q114 (3) L156 (1) Asn4P N70 (6) N70 (2) R155 (6) R155 (6) Phe5P N70 (7) N70 (7) Y116 (3) Y116 (2) F74 (3) F74 (5) Q114 (3) Q114 (4) V97 (1) V97 (1) Before our studies, many groups have reported design of ri mimics of immune epitopes. There are several instances of the ri version of a B cell epitope exhibiting similar immune response properties as those of the native peptide, while there are certain other instances where ri analogs did not show functional mimicry (21,22). A critical aspect of designing ri analog of any peptide is the interchange of the N-and the C-termini of the peptide.…”
Section: Discussionmentioning
confidence: 99%
“…(3) Y171(4) E63 (5) E63(3) Y159 (4) Y159 (3) K66 (2) T163 (2) Ile2P Y159 (2) Y159 (5) E63 (1) E63 (5) K66 (6) K66(3) E24 (5) E24 (4) Y45 (1) N70 (4) K66 (2) Ile3P Y159 (11) Y159 (17) R155 (2) S99 (2) L156 (1) Q114 (3) L156 (1) Asn4P N70 (6) N70 (2) R155 (6) R155 (6) Phe5P N70 (7) N70 (7) Y116 (3) Y116 (2) F74 (3) F74 (5) Q114 (3) Q114 (4) V97 (1) V97 (1) Before our studies, many groups have reported design of ri mimics of immune epitopes. There are several instances of the ri version of a B cell epitope exhibiting similar immune response properties as those of the native peptide, while there are certain other instances where ri analogs did not show functional mimicry (21,22). A critical aspect of designing ri analog of any peptide is the interchange of the N-and the C-termini of the peptide.…”
Section: Discussionmentioning
confidence: 99%
“…RI peptides corresponding to the immunodominant B and T cell epitopes of B13 failed to cross-react with anti-B13 antibodies in the sera from T. cruzi-infected patients and was not recognized by peripheral blood mononuclear cells obtained from individuals responding to the specific immunodominant T-cell epitope of B13. 45 This finding suggests that cross-reactivity with the natural epitope and its induced antibody may not be a general property of the corresponding RI peptides, implying that their use as synthetic vaccines and immunotherapeutic agents will be case-dependent.…”
Section: Ri Peptides As Immunogens Immunomodulators and Diagnostic mentioning
confidence: 99%
“…It has been reported that peripheral T cells from P. falciparum malaria patients recognize T cell epitopes in EB200, a repetitive region of the P. falciparum antigen Pf332, the Pf155 repetitive domain of ring-infected erythrocyte surface antigen (RESA) and the repetitive domain of circumsporozoite CS protein [14, 15]. We have previously shown that PBMC proliferative and cytokine responses to B13 and its synthetic peptides are frequent among T. cruzi -infected subjects [8, 16]. We also found that T cell responses to B13 protein are restricted to patients carrying certain HLA class II alleles (HLA-DQA1*0501(DQ7), HLA-DR1, and HLA-DR2), which bind and present B13 peptides directly [8].…”
Section: Introductionmentioning
confidence: 99%